Filing Details

Accession Number:
0001415889-15-003934
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-30 16:40:26
Reporting Period:
2015-11-09
Filing Date:
2015-11-30
Accepted Time:
2015-11-30 16:40:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1591165 Medovex Corp. MDVX Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033742 Steve Gorlin 3279 Hardee Avenue
Atlanta GA 30341
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-24 40,000 $1.45 369,462 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Convertible Note Acquisiton 2015-11-09 1 $2,000,000.00 0 $0.00
Common Stock Warrants Acquisiton 2015-11-09 500,000 $1,100,000.00 500,000 $2.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 2015-11-09 2015-11-09 No 4 P Direct
0 2015-11-09 2018-11-09 No 4 P Direct
Footnotes
  1. Includes 125,000 shares held by Mr. Gorlin's spouse, Deborah Gorlin. Mr. Gorlin disclaims beneficial ownership of Deborah Gorlin's shares.
  2. On November 9, 2015, the Company issued a convertible promissory note (the "Note") to Steve Gorlin. The Note's principal amount is $2,000,000 and bears interest at a rate of 5.5% annually and will mature two years from the issuance date. The Note is convertible such number of shares of common stock equal to the quotient of (a) the outstanding principal amount and accrued interest of the Note as of date of conversion, divided by (b) $2.00, subject to adjustment.
  3. In addition to the Note, the Reporting Person received a warrant to purchase 500,000 shares of common stock, exercisable at $2.20 per share for three years.